890 related articles for article (PubMed ID: 17009160)
1. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer.
Duong C; Greenawalt DM; Kowalczyk A; Ciavarella ML; Raskutti G; Murray WK; Phillips WA; Thomas RJ
Ann Surg Oncol; 2007 Dec; 14(12):3602-9. PubMed ID: 17896157
[TBL] [Abstract][Full Text] [Related]
3. REG Ialpha is a reliable marker of chemoradiosensitivity in squamous cell esophageal cancer patients.
Hayashi K; Motoyama S; Sugiyama T; Izumi J; Anbai A; Nanjo H; Watanabe H; Maruyama K; Minamiya Y; Koyota S; Koizumi Y; Takasawa S; Murata K; Ogawa J
Ann Surg Oncol; 2008 Apr; 15(4):1224-31. PubMed ID: 18259819
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
5. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of planned esophagectomy after neoadjuvant chemoradiotherapy for advanced esophageal carcinomas.
Kato H; Fukuchi M; Manda R; Faried A; Takita J; Nakajima M; Miyazaki T; Sohda M; Fukai Y; Masuda N; Tsukada K; Kuwano H
Anticancer Res; 2004; 24(6):4091-6. PubMed ID: 15736457
[TBL] [Abstract][Full Text] [Related]
7. [New trends in neoadjuvant chemoradiotherapy for locally-advanced esophageal cancer: esophagectomy--is it necessary?].
Fujita H; Sueyoshi S; Tanaka T; Toh U; Mine T; Sasahara H; Shirouzu K; Yamana H; Toda Y; Hayabuchi N
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2016-22. PubMed ID: 11103231
[TBL] [Abstract][Full Text] [Related]
8. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
[TBL] [Abstract][Full Text] [Related]
9. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.
Fujita H; Sueyoshi S; Tanaka T; Tanaka Y; Sasahara H; Shirouzu K; Suzuki G; Hayabuchi N; Inutsuka H
J Surg Oncol; 2005 Jun; 90(4):209-19. PubMed ID: 15906363
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma.
He LR; Liu MZ; Li BK; Rao HL; Deng HX; Guan XY; Zeng YX; Xie D
Cancer Sci; 2009 Sep; 100(9):1591-6. PubMed ID: 19552757
[TBL] [Abstract][Full Text] [Related]
12. [Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial].
Fu JH; Rong TH; Li XD; Hu Y; Ou W; Hu YH; Li Q
Ai Zheng; 2004 Nov; 23(11 Suppl):1473-6. PubMed ID: 15566661
[TBL] [Abstract][Full Text] [Related]
13. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
Xi H; Baldus SE; Warnecke-Eberz U; Brabender J; Neiss S; Metzger R; Ling FC; Dienes HP; Bollschweiler E; Moenig S; Mueller RP; Hoelscher AH; Schneider PM
Clin Cancer Res; 2005 Dec; 11(23):8341-7. PubMed ID: 16322294
[TBL] [Abstract][Full Text] [Related]
14. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer.
Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Nishida T; Mori M; Doki Y
J Surg Oncol; 2009 Nov; 100(6):442-6. PubMed ID: 19653262
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
[TBL] [Abstract][Full Text] [Related]
16. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.
Miyata H; Yoshioka A; Yamasaki M; Nushijima Y; Takiguchi S; Fujiwara Y; Nishida T; Mano M; Mori M; Doki Y
Cancer; 2009 Jul; 115(14):3324-34. PubMed ID: 19452547
[TBL] [Abstract][Full Text] [Related]
17. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.
Ancona E; Ruol A; Santi S; Merigliano S; Sileni VC; Koussis H; Zaninotto G; Bonavina L; Peracchia A
Cancer; 2001 Jun; 91(11):2165-74. PubMed ID: 11391598
[TBL] [Abstract][Full Text] [Related]
18. Interval between neoadjuvant chemoradiotherapy and surgery for squamous cell carcinoma of the thoracic esophagus: does delayed surgery have an impact on outcome?
Ruol A; Rizzetto C; Castoro C; Cagol M; Alfieri R; Zanchettin G; Cavallin F; Michieletto S; Da Dalt G; Sileni VC; Corti L; Mantoan S; Zaninotto G; Ancona E
Ann Surg; 2010 Nov; 252(5):788-96. PubMed ID: 21037434
[TBL] [Abstract][Full Text] [Related]
19. Chemoradiotherapy for T3 and T4 squamous cell carcinoma of the esophagus using low-dose FP and radiation: a preliminary report.
Fujiwara Y; Kamikonya N; Inoue T; Koishi K; Yoshikawa R; Nakao K; Yagyu R; Nishiwaki M; Fujiwara M; Kojima S; Nakagawa K; Yamamura T
Oncol Rep; 2005 Nov; 14(5):1177-82. PubMed ID: 16211282
[TBL] [Abstract][Full Text] [Related]
20. Chemoradiotherapy with and without esophagectomy for advanced esophageal cancer.
Nakamura T; Ota M; Hayashi K; Eguchi R; Ide H; Takasaki K; Mitsuhashi N
Hepatogastroenterology; 2006; 53(71):705-9. PubMed ID: 17086873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]